APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Cell Banking Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Immune Cell Banking Service Market Outlook and Growth Opportunities 2026

2 May 2026191 pages

Choose your research edition.

Industry ResearchImmune Cell Banking Service Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Cell Banking Service Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Immune Cell Banking Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Cell Banking Service Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Cell Banking Service Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

The global Immune Cell Banking Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immune Cell Banking Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immune Cell Banking Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune Cell Banking Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immune Cell Banking Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immune Cell Banking Service market include HealthBanks, BioLife Solutions, Sartorius, ThermoGenesis, Charles River, Biorep Technologies, Cryo-Cell International, CGT GLOBAL and Cordlife Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Immune Cell Banking Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immune Cell Banking Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune Cell Banking Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Immune Cell Banking Service market.

Immune Cell Banking Service Segment by Company

HealthBanks

BioLife Solutions

Sartorius

ThermoGenesis

Charles River

Biorep Technologies

Cryo-Cell International

CGT GLOBAL

Cordlife Group

Celularity

Boyalife

Beike Biotechnology

Forever Labs

Redermis

LifeCell International

VCANBIO

BGI Group

Shanghai Cell Therapy Group

Immune Cell Banking Service Segment by Type

Neonatal Immune Cell Storage

Adult Immune Cell Storage

Immune Cell Banking Service Segment by Application

Medical Scene

Non-medical Scene

Immune Cell Banking Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Immune Cell Banking Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Immune Cell Banking Service key companies, revenue, market share, and recent developments.

3. To split the Immune Cell Banking Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Immune Cell Banking Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immune Cell Banking Service significant trends, drivers, influence factors in global and regions.

6. To analyze Immune Cell Banking Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Cell Banking Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Cell Banking Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Cell Banking Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune Cell Banking Service industry.

Chapter 3: Detailed analysis of Immune Cell Banking Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Immune Cell Banking Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Immune Cell Banking Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immune Cell Banking Service Industry Trends Table 2. Immune Cell Banking Service Industry Drivers Table 3. Immune Cell Banking Service Industry Opportunities and Challenges Table 4. Immune Cell Banking Service Industry Restraints Table 5. Global Immune Cell Banking Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immune Cell Banking Service Revenue Share by Company (2021-2026) Table 7. Global Immune Cell Banking Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Immune Cell Banking Service Key Company Manufacturing Base & Headquarters Table 9. Global Immune Cell Banking Service Company, Product Type & Application Table 10. Global Immune Cell Banking Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Immune Cell Banking Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Neonatal Immune Cell Storage Table 15. Significant Companies of Adult Immune Cell Storage Table 16. Global Immune Cell Banking Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Immune Cell Banking Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Immune Cell Banking Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Immune Cell Banking Service Sales Value Share by Type (2021-2026) Table 20. Global Immune Cell Banking Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Scene Table 22. Significant Companies of Non-medical Scene Table 23. Global Immune Cell Banking Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Immune Cell Banking Service Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Immune Cell Banking Service Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Immune Cell Banking Service Sales Value Share by Application (2021-2026) Table 27. Global Immune Cell Banking Service Sales Value Share by Application (2027-2032) Table 28. Global Immune Cell Banking Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Immune Cell Banking Service Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Immune Cell Banking Service Sales Value Share by Region (2021-2026) Table 31. Global Immune Cell Banking Service Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Immune Cell Banking Service Sales Value Share by Region (2027-2032) Table 33. Global Immune Cell Banking Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Immune Cell Banking Service Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Immune Cell Banking Service Sales Value Market Share by Country (2021-2026) Table 36. Global Immune Cell Banking Service Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Immune Cell Banking Service Sales Value Market Share by Country (2027-2032) Table 38. HealthBanks Company Information Table 39. HealthBanks Business Overview Table 40. HealthBanks Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. HealthBanks Immune Cell Banking Service Product Portfolio Table 42. HealthBanks Recent Development Table 43. BioLife Solutions Company Information Table 44. BioLife Solutions Business Overview Table 45. BioLife Solutions Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. BioLife Solutions Immune Cell Banking Service Product Portfolio Table 47. BioLife Solutions Recent Development Table 48. Sartorius Company Information Table 49. Sartorius Business Overview Table 50. Sartorius Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Sartorius Immune Cell Banking Service Product Portfolio Table 52. Sartorius Recent Development Table 53. ThermoGenesis Company Information Table 54. ThermoGenesis Business Overview Table 55. ThermoGenesis Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. ThermoGenesis Immune Cell Banking Service Product Portfolio Table 57. ThermoGenesis Recent Development Table 58. Charles River Company Information Table 59. Charles River Business Overview Table 60. Charles River Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Charles River Immune Cell Banking Service Product Portfolio Table 62. Charles River Recent Development Table 63. Biorep Technologies Company Information Table 64. Biorep Technologies Business Overview Table 65. Biorep Technologies Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Biorep Technologies Immune Cell Banking Service Product Portfolio Table 67. Biorep Technologies Recent Development Table 68. Cryo-Cell International Company Information Table 69. Cryo-Cell International Business Overview Table 70. Cryo-Cell International Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cryo-Cell International Immune Cell Banking Service Product Portfolio Table 72. Cryo-Cell International Recent Development Table 73. CGT GLOBAL Company Information Table 74. CGT GLOBAL Business Overview Table 75. CGT GLOBAL Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CGT GLOBAL Immune Cell Banking Service Product Portfolio Table 77. CGT GLOBAL Recent Development Table 78. Cordlife Group Company Information Table 79. Cordlife Group Business Overview Table 80. Cordlife Group Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Cordlife Group Immune Cell Banking Service Product Portfolio Table 82. Cordlife Group Recent Development Table 83. Celularity Company Information Table 84. Celularity Business Overview Table 85. Celularity Immune Cell Banking Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Celularity Immune Cell Banking Service Product Portfolio Table 87. Celularity Recent Development Table 88. Boyalife Company Information Table 89. Boyalife Business Overview Table 90. Boyalife Immune Cell Banking Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Boyalife Immune Cell Banking Service Product Portfolio Table 92. Boyalife Recent Development Table 93. Beike Biotechnology Company Information Table 94. Beike Biotechnology Business Overview Table 95. Beike Biotechnology Immune Cell Banking Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Beike Biotechnology Immune Cell Banking Service Product Portfolio Table 97. Beike Biotechnology Recent Development Table 98. Forever Labs Company Information Table 99. Forever Labs Business Overview Table 100. Forever Labs Immune Cell Banking Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Forever Labs Immune Cell Banking Service Product Portfolio Table 102. Forever Labs Recent Development Table 103. Redermis Company Information Table 104. Redermis Business Overview Table 105. Redermis Immune Cell Banking Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Redermis Immune Cell Banking Service Product Portfolio Table 107. Redermis Recent Development Table 108. LifeCell International Company Information Table 109. LifeCell International Business Overview Table 110. LifeCell International Immune Cell Banking Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. LifeCell International Immune Cell Banking Service Product Portfolio Table 112. LifeCell International Recent Development Table 113. VCANBIO Company Information Table 114. VCANBIO Business Overview Table 115. VCANBIO Immune Cell Banking Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. VCANBIO Immune Cell Banking Service Product Portfolio Table 117. VCANBIO Recent Development Table 118. BGI Group Company Information Table 119. BGI Group Business Overview Table 120. BGI Group Immune Cell Banking Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. BGI Group Immune Cell Banking Service Product Portfolio Table 122. BGI Group Recent Development Table 123. Shanghai Cell Therapy Group Company Information Table 124. Shanghai Cell Therapy Group Business Overview Table 125. Shanghai Cell Therapy Group Immune Cell Banking Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Shanghai Cell Therapy Group Immune Cell Banking Service Product Portfolio Table 127. Shanghai Cell Therapy Group Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Immune Cell Banking Service Product Image Figure 2. Global Immune Cell Banking Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Cell Banking Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Immune Cell Banking Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Neonatal Immune Cell Storage Image Figure 8. Adult Immune Cell Storage Image Figure 9. Global Immune Cell Banking Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Immune Cell Banking Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Immune Cell Banking Service Sales Value Share by Type (2021-2032) Figure 12. Medical Scene Image Figure 13. Non-medical Scene Image Figure 14. Global Immune Cell Banking Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Immune Cell Banking Service Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Immune Cell Banking Service Sales Value Share by Application (2021-2032) Figure 17. Global Immune Cell Banking Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Immune Cell Banking Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Immune Cell Banking Service Sales Value (2021-2032) & (US$ Million) Figure 20. North America Immune Cell Banking Service Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Immune Cell Banking Service Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Immune Cell Banking Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Immune Cell Banking Service Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Immune Cell Banking Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Immune Cell Banking Service Sales Value (2021-2032) & (US$ Million) Figure 26. South America Immune Cell Banking Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Immune Cell Banking Service Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Immune Cell Banking Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Immune Cell Banking Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Neonatal Immune Cell Storage
  • Adult Immune Cell Storage
Applications
  • Medical Scene
  • Non-medical Scene
Companies covered
  • HealthBanks
  • BioLife Solutions
  • Sartorius
  • ThermoGenesis
  • Charles River
  • Biorep Technologies
  • Cryo-Cell International
  • CGT GLOBAL
  • Cordlife Group
  • Celularity
  • Boyalife
  • Beike Biotechnology
  • Forever Labs
  • Redermis
  • LifeCell International
  • VCANBIO
  • BGI Group
  • Shanghai Cell Therapy Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immune Cell Banking Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immune Cell Banking Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Immune Cell Banking Service Market Dynamics
  1. 2.1 Immune Cell Banking Service Industry Trends
  2. 2.2 Immune Cell Banking Service Industry Drivers
  3. 2.3 Immune Cell Banking Service Industry Opportunities and Challenges
  4. 2.4 Immune Cell Banking Service Industry Restraints
3 Immune Cell Banking Service Market by Company
  1. 3.1 Global Immune Cell Banking Service Company Revenue Ranking in 2025
  2. 3.2 Global Immune Cell Banking Service Revenue by Company (2021-2026)
  3. 3.3 Global Immune Cell Banking Service Company Ranking (2024-2026)
  4. 3.4 Global Immune Cell Banking Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Immune Cell Banking Service Company Product Type and Application
  6. 3.6 Global Immune Cell Banking Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Immune Cell Banking Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Immune Cell Banking Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Immune Cell Banking Service Market by Type
  1. 4.1 Immune Cell Banking Service Type Introduction
  2. 4.1.1 Neonatal Immune Cell Storage
  3. 4.1.2 Adult Immune Cell Storage
  4. 4.2 Global Immune Cell Banking Service Sales Value by Type
  5. 4.2.1 Global Immune Cell Banking Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Immune Cell Banking Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Immune Cell Banking Service Sales Value Share by Type (2021-2032)
5 Immune Cell Banking Service Market by Application
  1. 5.1 Immune Cell Banking Service Application Introduction
  2. 5.1.1 Medical Scene
  3. 5.1.2 Non-medical Scene
  4. 5.2 Global Immune Cell Banking Service Sales Value by Application
  5. 5.2.1 Global Immune Cell Banking Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Immune Cell Banking Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Immune Cell Banking Service Sales Value Share by Application (2021-2032)
6 Immune Cell Banking Service Regional Value Analysis
  1. 6.1 Global Immune Cell Banking Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immune Cell Banking Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Immune Cell Banking Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Immune Cell Banking Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immune Cell Banking Service Sales Value (2021-2032)
  7. 6.3.2 North America Immune Cell Banking Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Immune Cell Banking Service Sales Value (2021-2032)
  10. 6.4.2 Europe Immune Cell Banking Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Immune Cell Banking Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Immune Cell Banking Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Immune Cell Banking Service Sales Value (2021-2032)
  16. 6.6.2 South America Immune Cell Banking Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Immune Cell Banking Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Immune Cell Banking Service Sales Value Share by Country, 2025 VS 2032
7 Immune Cell Banking Service Country-level Value Analysis
  1. 7.1 Global Immune Cell Banking Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immune Cell Banking Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Immune Cell Banking Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Immune Cell Banking Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Immune Cell Banking Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Immune Cell Banking Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Immune Cell Banking Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 HealthBanks
  2. 8.1.1 HealthBanks Company Information
  3. 8.1.2 HealthBanks Business Overview
  4. 8.1.3 HealthBanks Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 HealthBanks Immune Cell Banking Service Product Portfolio
  6. 8.1.5 HealthBanks Recent Developments
  7. 8.2 BioLife Solutions
  8. 8.2.1 BioLife Solutions Company Information
  9. 8.2.2 BioLife Solutions Business Overview
  10. 8.2.3 BioLife Solutions Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioLife Solutions Immune Cell Banking Service Product Portfolio
  12. 8.2.5 BioLife Solutions Recent Developments
  13. 8.3 Sartorius
  14. 8.3.1 Sartorius Company Information
  15. 8.3.2 Sartorius Business Overview
  16. 8.3.3 Sartorius Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sartorius Immune Cell Banking Service Product Portfolio
  18. 8.3.5 Sartorius Recent Developments
  19. 8.4 ThermoGenesis
  20. 8.4.1 ThermoGenesis Company Information
  21. 8.4.2 ThermoGenesis Business Overview
  22. 8.4.3 ThermoGenesis Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ThermoGenesis Immune Cell Banking Service Product Portfolio
  24. 8.4.5 ThermoGenesis Recent Developments
  25. 8.5 Charles River
  26. 8.5.1 Charles River Company Information
  27. 8.5.2 Charles River Business Overview
  28. 8.5.3 Charles River Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Charles River Immune Cell Banking Service Product Portfolio
  30. 8.5.5 Charles River Recent Developments
  31. 8.6 Biorep Technologies
  32. 8.6.1 Biorep Technologies Company Information
  33. 8.6.2 Biorep Technologies Business Overview
  34. 8.6.3 Biorep Technologies Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biorep Technologies Immune Cell Banking Service Product Portfolio
  36. 8.6.5 Biorep Technologies Recent Developments
  37. 8.7 Cryo-Cell International
  38. 8.7.1 Cryo-Cell International Company Information
  39. 8.7.2 Cryo-Cell International Business Overview
  40. 8.7.3 Cryo-Cell International Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cryo-Cell International Immune Cell Banking Service Product Portfolio
  42. 8.7.5 Cryo-Cell International Recent Developments
  43. 8.8 CGT GLOBAL
  44. 8.8.1 CGT GLOBAL Company Information
  45. 8.8.2 CGT GLOBAL Business Overview
  46. 8.8.3 CGT GLOBAL Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CGT GLOBAL Immune Cell Banking Service Product Portfolio
  48. 8.8.5 CGT GLOBAL Recent Developments
  49. 8.9 Cordlife Group
  50. 8.9.1 Cordlife Group Company Information
  51. 8.9.2 Cordlife Group Business Overview
  52. 8.9.3 Cordlife Group Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cordlife Group Immune Cell Banking Service Product Portfolio
  54. 8.9.5 Cordlife Group Recent Developments
  55. 8.10 Celularity
  56. 8.10.1 Celularity Company Information
  57. 8.10.2 Celularity Business Overview
  58. 8.10.3 Celularity Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Celularity Immune Cell Banking Service Product Portfolio
  60. 8.10.5 Celularity Recent Developments
  61. 8.11 Boyalife
  62. 8.11.1 Boyalife Company Information
  63. 8.11.2 Boyalife Business Overview
  64. 8.11.3 Boyalife Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Boyalife Immune Cell Banking Service Product Portfolio
  66. 8.11.5 Boyalife Recent Developments
  67. 8.12 Beike Biotechnology
  68. 8.12.1 Beike Biotechnology Company Information
  69. 8.12.2 Beike Biotechnology Business Overview
  70. 8.12.3 Beike Biotechnology Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beike Biotechnology Immune Cell Banking Service Product Portfolio
  72. 8.12.5 Beike Biotechnology Recent Developments
  73. 8.13 Forever Labs
  74. 8.13.1 Forever Labs Company Information
  75. 8.13.2 Forever Labs Business Overview
  76. 8.13.3 Forever Labs Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Forever Labs Immune Cell Banking Service Product Portfolio
  78. 8.13.5 Forever Labs Recent Developments
  79. 8.14 Redermis
  80. 8.14.1 Redermis Company Information
  81. 8.14.2 Redermis Business Overview
  82. 8.14.3 Redermis Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Redermis Immune Cell Banking Service Product Portfolio
  84. 8.14.5 Redermis Recent Developments
  85. 8.15 LifeCell International
  86. 8.15.1 LifeCell International Company Information
  87. 8.15.2 LifeCell International Business Overview
  88. 8.15.3 LifeCell International Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 LifeCell International Immune Cell Banking Service Product Portfolio
  90. 8.15.5 LifeCell International Recent Developments
  91. 8.16 VCANBIO
  92. 8.16.1 VCANBIO Company Information
  93. 8.16.2 VCANBIO Business Overview
  94. 8.16.3 VCANBIO Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 VCANBIO Immune Cell Banking Service Product Portfolio
  96. 8.16.5 VCANBIO Recent Developments
  97. 8.17 BGI Group
  98. 8.17.1 BGI Group Company Information
  99. 8.17.2 BGI Group Business Overview
  100. 8.17.3 BGI Group Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BGI Group Immune Cell Banking Service Product Portfolio
  102. 8.17.5 BGI Group Recent Developments
  103. 8.18 Shanghai Cell Therapy Group
  104. 8.18.1 Shanghai Cell Therapy Group Company Information
  105. 8.18.2 Shanghai Cell Therapy Group Business Overview
  106. 8.18.3 Shanghai Cell Therapy Group Immune Cell Banking Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shanghai Cell Therapy Group Immune Cell Banking Service Product Portfolio
  108. 8.18.5 Shanghai Cell Therapy Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst